K243234

Substantially Equivalent

Second Opinion® CS

Applicant: Pearl, Inc.
Product code: MYN
Advisory panel: Radiology
Date received: 2024-10-10
Decision date: 2025-06-12
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Beverly Hills, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.